ArticleMolecular biology reports2025
Discovering the pathogenesis of a VUS variant in CDH23 associated with sensorineural hearing loss in an Iranian family.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHearing loss (HL) is a highly heterogeneous condition with concerning statistics, particularly given the significant occurrence of consanguineous marriages in Iran. Despite the presence of variants of uncertain significance (VUS), high-yield prenatal screening remains unattainable. This article aims to discuss a VUS mutation as a potential cause of HL in a sibling, with the goal of reclassifying this variant.
methodsThis research examined a sibling with congenital HL. Their parents were first cousins, and no non-genetic factors for the disease were identified. Whole exome sequencing (WES) was conducted to ascertain the genetic etiology of the disease, subsequently validated by Sanger sequencing. The stability and interactions of the mutated protein were then evaluated.
resultsThe homozygous variant CDH23 (NM_022124.6) c.5149T > C; p.C1717R has been suggested as the probable causative mutation. This variant was identified as a homozygous mutant in both patients and a heterozygous variant in healthy individuals. The mutation enhances the stability of this protein, whereas the interaction with the protein PCDH15, which plays a role in hemophilic stereocilia attachment, is entirely abolished in the areas surrounding the mutation. This protein interaction site is completely altered post-mutation, significantly reducing complex stability.
conclusionA homozygous variant in the CDH23 gene was identified in two patients from the same pedigree as a consequence of this investigation. Consequently, in light of the findings of this investigation, it is advised that additional in silico studies, including molecular dynamics simulations and in vitro studies, be conducted to assist in the reclassification of this variant, thereby enabling more precise genetic counseling.
Indexed as
Identifiers
40047980What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.